Real-world Study of Trastuzumab Deruxtecan in Patients With Unresectable or Metastatic HER2-low Breast Cancer

NCT06727227 · clinicaltrials.gov ↗

RECRUITING

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: trastuzumab deruxtecan

Sponsor

AstraZeneca